Zhenghong Yu

1.4k citations
44 papers · 1.1k indexed · h-index 16
Topics
Cancer-related gene regulation (5 papers)Nanoplatforms for cancer theranostics (5 papers)Epigenetics and DNA Methylation (5 papers)
Journals
Angewandte Chemie International EditionSHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Zhenghong Yu

39 papers receiving 1.1k citations

Peers

Zhenghong Yu
Comparison fields: 5 of 124
  • Molecular Biology 463
  • Control and Systems Engineering 333
  • Oncology 219
  • Cancer Research 105
  • Biomedical Engineering 72
Replace Na Chai with:
Na Chai China
Jinling Wang China
Huimin Tao China
Sanghee Kang South Korea
Yafan Wang China
Yajing Sun China
Ya-Fen Hsu Taiwan
Liang‐Ting Lin Taiwan
Xinpeng Yao China
Huimin Li China
Zhenghong Yu relative to Na Chai China Na Chai's profile →
Citations per field
00.5×2.6×
Na Chai · 1×
Citations per year

Countries citing papers authored by Zhenghong Yu

Since Specialization
Citations

This map shows the geographic impact of Zhenghong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenghong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenghong Yu more than expected).

Fields of papers citing papers by Zhenghong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenghong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenghong Yu. The network helps show where Zhenghong Yu may publish in the future.

Co-authorship network of co-authors of Zhenghong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenghong Yu. A scholar is included among the top collaborators of Zhenghong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenghong Yu. Zhenghong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 9
6 5
7 9
8 2
9 15
10 0
11 0
12 13
13 7
14 25
15 28
16 13
17 13
18 24
19 17
20 71

About Zhenghong Yu

Zhenghong Yu is a scholar working on Oncology, Molecular Biology and Internal Medicine, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related gene regulation (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Control and Systems Engineering (333 citations), Oncology (219 citations) and Cancer Research (105 citations). Zhenghong Yu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jay H. Lee, Shuangshuang Chen, Anna Junjie Shangguan, Longbang Chen, Tangfeng Lv, Luo Zhang, Yucai Wang, Shuang Zhao, Liming Chen and Yuan Gu. Their work appears in journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026